As such, we were interested in the potential mechanisms driving differential PEDF expression and function under pre- versus post-menopausal oestrogen conditions, and specifically the pro-metastatic biomarkers potentially differentially regulated by PEDF under menopausal conditions in BC cells. The gene discussed is SERPINF1; the disease is breast cancer.